Request Demo
Last update 03 Dec 2025
Human Cord derived MSC(Tianjin Amcellgene Engineering)
Last update 03 Dec 2025
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms 注射用间充质干细胞（脐带）, 脐带间充质干细胞注射液 |
Target- |
Action- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
7
Clinical Trials associated with Human Cord derived MSC(Tianjin Amcellgene Engineering)CTR20250672
一项评价注射用间充质干细胞（脐带）治疗慢加急性肝衰竭的多中心、随机、双盲、安慰剂平行对照Ⅱb/Ⅲ期操作无缝适应性设计临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase IIb/III seamless adaptive design clinical study to evaluate the efficacy of injectable mesenchymal stem cells (umbilical cord) in the treatment of acute-on-chronic liver failure
CTR20242174
注射用间充质干细胞（脐带）治疗急性缺血性脑卒中（AIS）患者安全性、耐受性及
初步疗效的单臂、开放探索期临床研究
[Translation] A single-arm, open-label exploratory clinical study on the safety, tolerability and preliminary efficacy of injectable mesenchymal stem cells (umbilical cord) in the treatment of patients with acute ischemic stroke (AIS)
CTR20233388
注射用间充质干细胞（脐带）治疗外伤性脊髓损伤单臂、开放、多中心探索性临床研究
[Translation] A single-arm, open, multi-center exploratory clinical study on the use of injectable mesenchymal stem cells (umbilical cord) in the treatment of traumatic spinal cord injury
100 Clinical Results associated with Human Cord derived MSC(Tianjin Amcellgene Engineering)
Login to view more data
100 Translational Medicine associated with Human Cord derived MSC(Tianjin Amcellgene Engineering)
Login to view more data
100 Patents (Medical) associated with Human Cord derived MSC(Tianjin Amcellgene Engineering)
Login to view more data
100 Deals associated with Human Cord derived MSC(Tianjin Amcellgene Engineering)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute-On-Chronic Liver Failure | Phase 3 | China | 25 Apr 2025 | |
| Traumatic spinal cord injury | Phase 2 | China | 15 Mar 2024 | |
| Infectious Diseases | Phase 2 | China | 06 May 2023 | |
| Respiratory Distress Syndrome, Adult | Phase 2 | China | 06 May 2023 | |
| Acute Ischemic Stroke | Phase 1 | China | 08 Aug 2024 | |
| Refractory Acute Graft Versus Host Disease | Phase 1 | China | 31 Dec 2020 | |
| Diabetic Nephropathies | IND Approval | China | 03 Dec 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free